Pemigatinib is a type of TKI that’s made to mostly stop the FGFR2 kinase from working when it’s fused or changed. It’s used to treat a type of liver cancer called cholangiocarcinoma, especially if the cancer has this FGFR2 fusion gene. You can get it in 4.5 mg, 9 mg, or 13.5 mg tablets.
For adults who can swallow pills, the suggested dose is 13.5 mg taken once every day for 14 days out of every 21 days. You usually take it in 21-day cycles, one right after the other. Each bottle has 14 tablets, enough for a 14-day stretch of the 13.5 mg dose taken once a day.
